Laura Izquierdo-Sanchez (Laura Izquierdo-Sánchez)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Neoadjuvant Chemotherapy

Cross Sectional

Sentinel Lymph Node

Top Venues

United European gastroenterology journal

This page only lists publications with an associated author ORCID identifier.

Publications

Leonardo Gomes da Fonseca, Pedro H Hashizume, Irai Santana de Oliveira, Laura Izquierdo-Sanchez, Lisa Rodrigues da Cunha Saud, Mariana Pinheiro Xerfan, Venancio Avancini Ferreira Alves, Evandro Sobroza de Mello, Paulo Herman, Jesus M Banales, Claudia P Oliveira, Flair J Carrilho
Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence. Cancers 14 (14) (2022)
Lynn E Nooijen, Jesus M Banales, Marieke T de Boer, Chiara Braconi, Trine Folseraas, Alejandro Forner, Waclaw Holowko, Frederik J H Hoogwater, Heinz-Josef Klümpen, Bas Groot Koerkamp, Angela Lamarca, Adelaida La Casta, Flora López-López, Laura Izquierdo-Sanchez, Alexander Scheiter, Kirsten Utpatel, Rutger-Jan Swijnenburg, Geert Kazemier, Joris I Erdmann, null null
Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry. Cancers 14 (10) (2022)
Laura Izquierdo-Sanchez, Jesus Maria Banales, Pedro M Rodrigues
A look back at cholangiocarcinoma in Finland. United European gastroenterology journal (2021)
Isabel Solares, Laura Izquierdo-Sanchez, Montserrat Morales-Conejo, Daniel Jericó, Francisco Javier Castelbón, Karol Marcela Córdoba, Ana Sampedro, Carlos Lumbreras, María Jesús Moreno-Aliaga, Rafael Enríquez de Salamanca, Pedro Berraondo, Antonio Fontanellas
High Prevalence of Insulin Resistance in Asymptomatic Patients with Acute Intermittent Porphyria and Liver-Targeted Insulin as a Novel Therapeutic Approach. Biomedicines 9 (3) (2021)